InnoCare Pharma Limited (09969)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chen Kaixian | 11-Mar-20 | 25-Sep-24 | INED | He needs more time for his dedication in academic research as an academician of the Chinese Academy of Sciences. | |
| Cui Jisong | 03-Nov-15 | Ch, CEO | |||
| Dong Dandan | 11-Oct-23 | INED | |||
| Fu Shan | 05-Feb-18 | 27-Mar-23 | NED | ||
| Guan Kunliang | 21-Jan-25 | INED | |||
| Hu Lan | 11-Mar-20 | INED | |||
| Jin Ming | 31-Mar-22 | 25-Sep-24 | NED | To devote more time on his primary responsibilities as a partner in Beijing Hankang Venture Capital Management Co., Ltd. | |
| Lee Angel Pui Shan | 23-Mar-22 | 25-Mar-26 | CoSec | Resignation. | |
| Lin Lijun | 28-Nov-18 | 31-Mar-21 | NED | ||
| Shi Yigong | 28-Nov-18 | NED | |||
| Wong Keith Shing Cheung | 09-Feb-21 | 23-Mar-22 | CoSec | ||
| Xie Ronggang | 31-Mar-21 | NED | |||
| Yeung Ching Man | 27-Sep-19 | 09-Feb-21 | CoSec | ||
| Yuan Quanhong | 31-Jul-19 | 31-Mar-22 | NED | ||
| Zhang Jason Zemin | 06-Mar-16 | 14-Jul-23 | INED | Needed more time for his dedication in academic research as a tenured professor at the School of Life Sciences of Peking University | |
| Zhao Renbin | 03-Nov-15 | ED |